Abstract: The present invention encompasses a diagnostic test and method to authenticate the veracity of a vaccine. The diagnostic test and method are especially useful in a specific and sensitive immunochromatographic assay, performable within about 15 minutes for the authentication, validation, and veracity of a vaccine, such as a COVID-19 vaccine, in a vial prior to administration to a human.
Type:
Grant
Filed:
May 14, 2021
Date of Patent:
December 28, 2021
Assignee:
Quantum Materials Corporation
Inventors:
Andrew Robinson, Krishna Kowlgi, Stephen Squires, Brent Wade Ferguson, Nathanael J. Barree
© 2024 Justia
